ULCERATIVE COLITIS

Changing nationwide trends in endoscopic, medical and surgical admissions for inflammatory bowel disease: 2003–2013
Ahmir Ahmad, Anthony A Laverty, Chris Alexakis, Tom Cowling, Sonia Saxena, Azeem Majeed, Richard C G Pollok

BMJ Open Gastroenterology Mar 2018, 5 (1) e000191; DOI: 10.1136/bmjgast-2017-000191
Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD
Christoffer Soendergaard, Jakob Benedict Seidelin, Casper Steenholdt, Ole Haagen Nielsen

BMJ Open Gastroenterology May 2018, 5 (1) e000208; DOI: 10.1136/bmjgast-2018-000208
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis
Alessia Finotti, Jessica Gasparello, Ilaria Lampronti, Lucia Carmela Cosenza, Giovanni Maconi, Vincenzo Matarese, Valentina Gentili, Dario Di Luca, Roberto Gambari, Michele Caselli

BMJ Open Gastroenterology Dec 2017, 4 (1) e000172; DOI: 10.1136/bmjgast-2017-000172
Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010–2014
Eboselume Akhuemonkhan, Alyssa Parian, Kay Miller, Stephen Hanauer, Susan Hutfless

BMJ Open Gastroenterology Jul 2017, 4 (1) e000155; DOI: 10.1136/bmjgast-2017-000155
Maternal inflammatory bowel disease and hypospadias in male offspring: a population-based study in Denmark
Ane Birgitte Telén Andersen, Vera Ehrenstein, Rune Erichsen, Trine Frøslev, Henrik Toft Sørensen

BMJ Open Gastroenterology Nov 2016, 3 (1) e000121; DOI: 10.1136/bmjgast-2016-000121
Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I
Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa

BMJ Open Gastroenterology Nov 2016, 3 (1) e000122; DOI: 10.1136/bmjgast-2016-000122
Usefulness of sulfasalazine for patients with refractory-ulcerative colits
Takuya Yoshino, Makoto Sono, Shujiro Yazumi

BMJ Open Gastroenterology Aug 2016, 3 (1) e000103; DOI: 10.1136/bmjgast-2016-000103
Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series
Mohamed Bekheit, Nahed Baddour, Khaled Katri, Yousry Taher, Khaled El Tobgy, Essam Mousa

BMJ Open Gastroenterology Apr 2016, 3 (1) e000082; DOI: 10.1136/bmjgast-2016-000082
Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis
Lauren Yokomizo, Berkeley Limketkai, K T Park

BMJ Open Gastroenterology May 2016, 3 (1) e000093; DOI: 10.1136/bmjgast-2016-000093
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
Silvio Danese, Ailsa Hart, Axel Dignass, Edouard Louis, Geert D'Haens, Iris Dotan, Gerhard Rogler, Laurence D'Agay, Claudio Iannacone, Laurent Peyrin-Biroulet

BMJ Open Gastroenterology May 2016, 3 (1) e000092; DOI: 10.1136/bmjgast-2016-000092

Main menu

ULCERATIVE COLITIS

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

ULCERATIVE COLITIS

Pages